102 related articles for article (PubMed ID: 30137201)
1. Anti-leprosy drug Clofazimine binds to human Raf1 kinase inhibitory protein and enhances ERK phosphorylation.
Guo C; Chang T; Sun T; Wu Z; Dai Y; Yao H; Lin D
Acta Biochim Biophys Sin (Shanghai); 2018 Oct; 50(10):1062-1067. PubMed ID: 30137201
[TBL] [Abstract][Full Text] [Related]
2. Cefotetan-bound human RKIP involves in Ras/Raf1/MEK/ERK signaling pathway.
Guo C; Xu H; Zhou Y; Wu Z; Jiang B; Chen H; Lin D
Acta Biochim Biophys Sin (Shanghai); 2022 Dec; 54(12):1917-1923. PubMed ID: 36789691
[TBL] [Abstract][Full Text] [Related]
3. Pranlukast, a novel binding ligand of human Raf1 kinase inhibitory protein.
Sun T; Wu Z; Luo M; Lin D; Guo C
Biotechnol Lett; 2016 Aug; 38(8):1375-80. PubMed ID: 27146207
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for RKIP binding with its substrate Raf1 kinase.
Wu Z; Fu C; Shi L; Ruan L; Lin D; Guo C
Biotechnol Lett; 2014 Sep; 36(9):1869-74. PubMed ID: 24863296
[TBL] [Abstract][Full Text] [Related]
5. Suramin Targets the Conserved Ligand-Binding Pocket of Human Raf1 Kinase Inhibitory Protein.
Guo C; Wu Z; Lin W; Xu H; Chang T; Dai Y; Lin D
Molecules; 2021 Feb; 26(4):. PubMed ID: 33670019
[TBL] [Abstract][Full Text] [Related]
6. The RKIP (Raf-1 Kinase Inhibitor Protein) conserved pocket binds to the phosphorylated N-region of Raf-1 and inhibits the Raf-1-mediated activated phosphorylation of MEK.
Rath O; Park S; Tang HH; Banfield MJ; Brady RL; Lee YC; Dignam JD; Sedivy JM; Kolch W; Yeung KC
Cell Signal; 2008 May; 20(5):935-41. PubMed ID: 18294816
[TBL] [Abstract][Full Text] [Related]
7. Positive- and negative-feedback regulations coordinate the dynamic behavior of the Ras-Raf-MEK-ERK signal transduction pathway.
Shin SY; Rath O; Choo SM; Fee F; McFerran B; Kolch W; Cho KH
J Cell Sci; 2009 Feb; 122(Pt 3):425-35. PubMed ID: 19158341
[TBL] [Abstract][Full Text] [Related]
8. 15-Lipoxygenase 1 interacts with phosphatidylethanolamine-binding protein to regulate MAPK signaling in human airway epithelial cells.
Zhao J; O'Donnell VB; Balzar S; St Croix CM; Trudeau JB; Wenzel SE
Proc Natl Acad Sci U S A; 2011 Aug; 108(34):14246-51. PubMed ID: 21831839
[TBL] [Abstract][Full Text] [Related]
9. Solution structure and backbone dynamics of human Raf-1 kinase inhibitor protein.
Guo C; Yi C; Peng Y; Wen Y; Lin D
Biochem Biophys Res Commun; 2013 Aug; 438(1):129-32. PubMed ID: 23872143
[TBL] [Abstract][Full Text] [Related]
10. Integrated bioinformatics, computational and experimental methods to discover novel Raf/extracellular-signal regulated kinase (ERK) dual inhibitors against breast cancer cells.
Chen Y; Zheng Y; Jiang Q; Qin F; Zhang Y; Fu L; He G
Eur J Med Chem; 2017 Feb; 127():997-1011. PubMed ID: 27839788
[TBL] [Abstract][Full Text] [Related]
11. Raf kinase inhibitor protein (RKIP) dimer formation controls its target switch from Raf1 to G protein-coupled receptor kinase (GRK) 2.
Deiss K; Kisker C; Lohse MJ; Lorenz K
J Biol Chem; 2012 Jul; 287(28):23407-17. PubMed ID: 22610096
[TBL] [Abstract][Full Text] [Related]
12. Regulation of human myoblast differentiation by PEBP4.
Garcia R; Grindlay J; Rath O; Fee F; Kolch W
EMBO Rep; 2009 Mar; 10(3):278-84. PubMed ID: 19197339
[TBL] [Abstract][Full Text] [Related]
13. A proteomic approach in investigating the hepatoprotective mechanism of Schisandrin B: role of raf kinase inhibitor protein.
Chen Y; Ip SP; Ko KM; Poon TC; Ng EW; Lai PB; Mao QQ; Xian YF; Che CT
J Proteome Res; 2011 Jan; 10(1):299-304. PubMed ID: 21155602
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
[TBL] [Abstract][Full Text] [Related]
15. Akt regulates vitamin D3-induced leukemia cell functional differentiation via Raf/MEK/ERK MAPK signaling.
Wang J; Zhao Y; Kauss MA; Spindel S; Lian H
Eur J Cell Biol; 2009 Feb; 88(2):103-15. PubMed ID: 19058874
[TBL] [Abstract][Full Text] [Related]
16. Raf kinase inhibitory protein function is regulated via a flexible pocket and novel phosphorylation-dependent mechanism.
Granovsky AE; Clark MC; McElheny D; Heil G; Hong J; Liu X; Kim Y; Joachimiak G; Joachimiak A; Koide S; Rosner MR
Mol Cell Biol; 2009 Mar; 29(5):1306-20. PubMed ID: 19103740
[TBL] [Abstract][Full Text] [Related]
17. Investigating dynamics of inhibitory and feedback loops in ERK signalling using power-law models.
Vera J; Rath O; Balsa-Canto E; Banga JR; Kolch W; Wolkenhauer O
Mol Biosyst; 2010 Nov; 6(11):2174-91. PubMed ID: 20717620
[TBL] [Abstract][Full Text] [Related]
18. The RAS/Raf1/MEK/ERK signaling pathway facilitates VSV-mediated oncolysis: implication for the defective interferon response in cancer cells.
Noser JA; Mael AA; Sakuma R; Ohmine S; Marcato P; Lee PW; Ikeda Y
Mol Ther; 2007 Aug; 15(8):1531-6. PubMed ID: 17505473
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the Raf kinase inhibitory protein (RKIP) binding pocket: NMR-based screening identifies small-molecule ligands.
Shemon AN; Heil GL; Granovsky AE; Clark MM; McElheny D; Chimon A; Rosner MR; Koide S
PLoS One; 2010 May; 5(5):e10479. PubMed ID: 20463977
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the MAPK pathway by raf kinase inhibitory protein.
Vandamme D; Herrero A; Al-Mulla F; Kolch W
Crit Rev Oncog; 2014; 19(6):405-15. PubMed ID: 25597351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
